June 11, 2020 / 4:42 PM / a month ago

BRIEF-Adial Pharmaceuticals Announces Approval To Commence Landmark Onward!" Pivotal Phase 3 Trial In Poland

June 11 (Reuters) - Adial Pharmaceuticals Inc:

* ADIAL PHARMACEUTICALS ANNOUNCES APPROVAL TO COMMENCE LANDMARK ONWARD!” PIVOTAL PHASE 3 TRIAL IN POLAND

* ADIAL PHARMACEUTICALS - TRIAL PROGRESS ACCELERATES AS HOST COUNTRIES REOPEN FOLLOWING COVID-19 LOCKDOWNS Source text - bit.ly/37sqcM3 Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below